Correction: Proteogenomic Analysis of Salivary Adenoid Cystic Carcinomas Defines Molecular Subtypes and Identifies Therapeutic Targets
Year: 2023
Type: erratum
Abstract: In the original version of this article (1), the Methods section contained two inaccuracies: MYC scoring was stated to be binary (positive, negative) when it was tertiary (high, low, negative), and the positive/negative benchmark for TP63 expression was stated to be at 70% of cells when it was at 10% of cells. The errors have been corrected in the latest online HTML and PDF versions of the article. The authors regret the errors.
Source: Clinical Cancer Research
Authors: Renata Ferrarotto, Yoshitsugu Mitani, Daniel J. McGrail, Kaiyi Li, Tatiana V. Karpinets, Diana Bell, Steven J. Frank, Xingzhi Song, Michael E. Kupferman, Bin Liu, J. Jack Lee, Bonnie S. Glisson, Jianhua Zhang, Jon C. Aster, Shiaw-Yih Lin, P. Andrew Futreal, John V. Heymach, Adel K. El-Naggar
Language: English
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W4384342201